Electronic health-record developers Allscripts-Misys Healthcare Solutions and Eclipsys Corp. have scheduled special shareholder meetings for Aug. 13 to allow votes on a $1.3 billion deal, announced June 9, to merge the companies.
According to the terms of the deal, Allscripts would acquire Eclipsys by issuing stock at premium to Eclipsys shareholders. That transaction is contingent upon Allscripts carrying out a leveraged buyback of shares from British information technology company Misys, which took a majority stake in a 2008 deal that joined its Misys Healthcare Systems unit with Allscripts.
The Allscripts vote will take place at the law offices of Sidley Austin in Chicago, where Allscripts is based, and Eclipsys will hold its vote at its Atlanta headquarters.
The merged company would be headed by Allscripts CEO Glen Tullman, who has pitched the union as an opportunity to offer providers an integrated platform across treatment settings. Whereas his company is a major player in outpatient facilities, Eclipsys has a major presence in hospitals.
Tullman discussed the Eclipsys deal with Modern Healthcare reporter Andis Robeznieks in June. Watch the video here.